Alterations in the copy number of the SULT1A1 gene
View Patent ↗Methods are described for determining sulfonator status of a patient and determining dosages of drugs based on copy number of the SULT1A1 gene.
1. A method of determining a relative level of SULT 1A1 activity in a human subject, said method comprising:
a) providing a biological sample comprising genomic DNA from said subject;
b) analyzing said genomic DNA to determine the copy number of the SULT1A1 gene in said biological sample; and
c) correlating copy number of the SULT1A1 gene with SULT1A1 activity in said subject, wherein more than two copies of the SULT1A1 gene is indicative of an increased level of SULT1A1 activity, and wherein two or less copies of the SULT1A1 gene is indicative of a decreased level of SULT1A1 activity.
2. The method of claim 1 , wherein said biological sample is a blood or tissue sample.
3. The method of claim 1 , wherein copy number of the SULT1A1 gene is detected by a quantitative PCR assay.
4. The method of claim 3 , wherein said quantitative PCR assay is a fluorescent quantitative PCR assay.
5. The method of claim 1 , wherein copy number of the SULT1A1 gene is detected by fluorescence in situ hybridization.
6. The method of claim 1 , wherein copy number of the SULT1A1 gene is detected by Southern blotting.
7. The method of claim 1 , wherein copy number of the SULT1A1 gene is detected by multiplex ligation-dependent probe amplification (MLPA).
8. The method of claim 1 , wherein copy number of the SULT1A1 gene is detected by Quantitative Multiplex PCR of Short Fluorescent Fragments (QMPSF).